These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation. Castroagudin JF, Delgado M, Martinez SM, Abdulkader I, Potel J, Tome S, Otero E, Varo E. Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645 [Abstract] [Full Text] [Related]
6. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis. Schaudt A, Kriener S, Schwarz W, Wullstein C, Zangos S, Vogl T, Mehrabi A, Fonouni H, Bechstein WO, Golling M. Clin Transplant; 2009 Dec; 23 Suppl 21():61-7. PubMed ID: 19930318 [Abstract] [Full Text] [Related]
7. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F. Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162 [Abstract] [Full Text] [Related]
8. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960 [Abstract] [Full Text] [Related]